甲状腺肿瘤中microRNA表达失调的研究进展

Deregulation of microRNA expression in thyroid tumors 甲状腺肿瘤中microRNA表达失调的研究进展 first-author corresp ‡Corresponding Author ‡Corresponding Author †E-mail:zhengqi1957@aliyun.com †E-mail:zhengqi1957@aliyun.com zhengqi1957@aliyun.com Department of General Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China Department of General Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China MicroRNAs (miRNAs or miRs) are endogenous non-coding RNAs that negatively regulate gene expression by binding to the 3' non-coding regions of target mRNAs, resulting in their cleavage or blocking their translation. miRNAs may have an impact on cell differentiation, proliferation, and survival, and their deregulation can be inclined to diseases and cancers, including thyroid tumors. The purpose of this review is to summarize the existing findings of deregulated miRNAs in different types of thyroid tumors and to exhibit their potential target genes, especially to demonstrate those involved in tumor invasion and metastasis. In addition, new findings of circulating miRNA expression profiles, single nucleotide polymorphism (SNP) in thyroid tumors, and the correlation of somatic mutations with deregulated miRNA expression in thyroid tumors were all included in this review. 研究目的 2 MicroRNAs（miRNAs或miRs）是一种内源性非编码RNA，通过与信使RNA（mRNA）的3'非编码区结合，引起mRNA的断裂或蛋白质翻译的阻断，进而对基因表达进行负性调控。miRNAs可影响细胞的分化、增殖和生存等过程，其表达失调有引起疾病甚至肿瘤的可能。miRNA表达失调已在多种人类肿瘤中出现，包括甲状腺肿瘤。本文对不同类型的甲状腺肿瘤中出现的miRNAs表达失调及miRNAs可能的下游靶基因进行综述，为甲状腺肿瘤的临床诊断及治疗提供依据。 创新要点 2 已有大量关于滤泡细胞起源，尤其是乳头状甲状腺癌（PTC）中miRNAs表达失调的综述，但对C细胞起源的甲状腺髓样癌（MTC）中miRNAs表达失调的研究并未形成系统。同时，在此之前没有关于各型甲状腺肿瘤miRNAs表达与其靶基因的综述报道。在这篇综述中，我们还列入了对甲状腺肿瘤患者外周循环血液中miRNAs表达谱的最新研究以及单核苷酸多态性（SNP）对甲状腺肿瘤的影响。 重要结论 2 总结了miRNAs在各型甲状腺肿瘤中的表达谱（见表1、3、4、6）；描述了在各型甲状腺肿瘤中不同miRNAs潜在的靶基因及其在肿瘤发生、发展、浸润、转移等多方面的作用（见图1；表2、5）。 MicroRNA Target gene Thyroid tumor Single nucleotide polymorphism (SNP) Somatic mutation MicroRNA 靶基因 甲状腺肿瘤 单核苷酸多态性 体细胞突变 Introduction 1 There are two distinct hormone-producing cell types composing the thyroid gland: follicular cells and parafollicular C cells (Pallante et al., 2010 2010 ). More than 95% of thyroid tumors are derived from the follicular cells, while only 3% are C-cell-derived carcinomas (Kondo et al., 2006 2006 ). Thyroid nodules are common and their prevalence differs from 3% to 76%, depending on the detection methods and the population evaluated (Ferraz et al., 2011 2011 ). Most thyroid nodules are benign and just 5% are malignant (Gharib, 2004 2004 ; Dean and Gharib, 2008 2008 ). Benign nodules are principally represented as follicular thyroid adenomas (FTAs). The malignant nodules are carcinomas mostly and the thyroid carcinomas are one of the most common malignancies of the endocrine system (Mazeh, 2012 2012 ). Depending on various histological and clinical features, the follicular cell-derived carcinomas are divided into well-differentiated thyroid carcinomas (WDTCs), poorly differentiated thyroid carcinomas (PDTCs), and undifferentiated thyroid carcinomas (Kondo et al., 2006 2006 ). WDTCs include papillary thyroid carcinomas (PTCs) and follicular thyroid carcinomas (FTCs). Anaplastic thyroid cancers (ATCs) are highly undifferentiated and extremely aggressive (Yau et al., 2008 2008 ; Braun and Hüttelmaier, 2011 2011 ). PDTCs are medium carcinomas between WDTCs and ATCs. Medullary thyroid cancers (MTCs), the neuroendocrine tumor of the thyroid gland, are derived from parafollicular C cells (Pallante et al., 2010 2010 ) and present as the hereditary form (HMTC; 25%) and the sporadic form (SMTC; 75%) (Abraham et al., 2011 2011 ). MicroRNAs (miRNAs or miRs) are small endogenous non-coding RNAs of 19–23 nucleotides that negatively regulate gene expressions by degrading mRNAs or blocking their translations (Ambros, 2004 2004 ; Bartel, 2004 2004 ). Productions and functions of miRNAs include multiple steps and require a large number of proteins (Nikiforova et al., 2009 2009 ). They are transcribed from endogenous DNA by RNA polymerase II, and then processed from primary transcript (pri-miRNAs) to hairpin precursor (pre-miRNAs), which comprise two strands (Vriens et al., 2012 2012 ). After that, they are exported by exportin-5 to the cytoplasm (Nikiforova et al., 2009 2009 ; Marini et al., 2011 2011 ). In the cytoplasm, pre-miRNAs undergo further processing by endonuclease Dicer and become mature miRNAs (Nikiforova et al., 2009 2009 ; Frezzetti et al., 2011a 2011a ; Marini et al., 2011 2011 ). Mature miRNAs can bind to the 3′ untranslated region (UTR) of mRNAs, resulting in blockage of translation or mRNA degradation depending on the degree of complementarity between miRNA and mRNA (Ambros, 2004 2004 ; Bartel, 2004 2004 ). Agretti et al. ( 2012 2012 ) reported that the number of known unique mature human miRNAs is 1921. The interaction between miRNA and mRNA is complex, partly because a single miRNA can target hundreds of different mRNA molecules (Ku and McManus, 2008 2008 ). The miRNAs can influence cell differentiation, metabolism, and apoptosis, etc. (Cowland et al., 2007 2007 ; Huang et al., 2010 2010 ). It has been reported that the deregulation of miRNAs is involved in numerous cancers, including thyroid tumors (Mattie et al., 2006 2006 ; Murakami et al., 2006 2006 ; Chin et al., 2011 2011 ). For example, five miRNAs (miR-146, -221, -222, -155, and -181a) were up-regulated in human PTCs as compared with normal human tissues (Menon and Khan, 2009 2009 ); four miRNAs (miR-192, -197, -328, and -346) were overexpressed in the FTC as compared with the follicular adenoma (FA) (Weber et al., 2006 2006 ); and significant decreases of miR-30d, -125b, -26a, and -30a-5p were detected in ATCs in comparison to normal thyroid tissues (Visone et al., 2007 2007 ). Thus, different tumor types have different miRNA expressions. Schwertheim et al. ( 2009 2009 ) reported that the miRNA expression pattern in thyroid cancers depends on the cellular origin and tumor differentiation. Recently, a lot of researches concerning miRNA alterations occurring in thyroid tumors have been performed. This improved knowledge has promoted the understanding about thyroid cancer etiology and has offered novel diagnostic and prognostic markers for thyroid tumors (Nikiforov and Nikiforova, 2011 2011 ). To our knowledge, this was the first review focused on summarizing different molecular alterations in every type of thyroid tumor, besides that, the deregulated miRNAs on thyroid tumor invasion, the circulating miRNA expression profiles, and single nucleotide polymorphism (SNP) in thyroid tumors and the correlation of somatic mutations with deregulated miRNA expression in thyroid tumors were all included in this review. We hope to offer some improved and personalized diagnostic markers for thyroid tumors. miRNA expression profiles in papillary thyroid carcinomas (PTCs) 1 Most studies analyzed miRNA expression profiles of PTCs using miRNA microarrays, and they revealed the up-regulation of seven miRNAs in PTCs compared with the normal thyroid, including miR-221, -222, -146, -21, -155, -181a, and -181b (Tetzlaff et al., 2007 2007 ; Nikiforova et al., 2008 2008 ). The up-regulation of miR-221, -222, and -181b showed the values of fold-change in some cases higher than 10 (Pallante et al., 2010 2010 ). Sheu et al. ( 2010 2010 ) showed a significant difference of the expression of miR-146b between PTCs and other benign thyroid lesions, such as multinodular goitre (MNG) and FA with fold-changes up to 90. Moreover, four different studies (He et al., 2005 2005 ; Ricarte-Filho et al., 2009 2009 ; Leone et al., 2011 2011 ; Xiong et al., 2011 2011 ) identified down-regulation of miRNAs in PTC in comparison to normal thyroid tissue. The different miRNA expression profiles in PTCs are shown in Table 1 1 . FFPE tissue: formalin-fixed paraffin-embedded tissue; RT-PCR: reverse transcription-polymerase chain reaction; qRT-PCR: quantitative real-time polymerase chain reaction miRNA Specimen type Detecting technique Experimental group Control group Expression profile Reference miR-146, -221, -222, -21, -220, -181a, -155 Snap-frozen tissue miRNA microarrays Tumor tissue Normal thyroid tissue Up He et al., 2005 2005 miR-187, -221, -222, -146b, -155, -122a, -31, -205, -224 Snap-frozen tissue RT-PCR Tumor tissue Normal thyroid tissue Up Nikiforova et al., 2008 2008 miR-221, -222, -21, -31, -172, -34a, -213, -181b, -223, -224, -181a FFPE tissue miRNA microarrays Tumor tissue Benign proliferative multinodular goiter Up Tetzlaff et al., 2007 2007 miR-146b, -221, -222 FFPE tissue qRT-PCR Tumor tissue Follicular adenoma Up Chen et al., 2008 2008 miR-218, -300, -292, -345, -30c, -30a-5p, -19b-1,2, -145sh, -130b FFPE tissue miRNA microarrays Tumor tissue Benign proliferative multinodular goiter Down Tetzlaff et al., 2007 2007 miR-886-3p, miR-20a Snap-frozen tissue miRNA microarrays Tumor tissue Normal thyroid tissue Down Xiong et al., 2011 2011 miR-1 Fresh thyroid tissue sample qRT-PCR Thyroid adenomas and carcinomas Normal thyroid tissue Down Leone et al., 2011 2011 miR-26a-1, -345, -138, -219 Snap-frozen tissue miRNA microarrays Tumor tissue Normal thyroid tissue Down He et al., 2005 2005 To understand how miRNAs play parts in neoplasia, many studies have been done to find the targets of miRNAs (Fig. 1 1 ). A computational search revealed that miR-146b-5p potentially binds to the 3′ UTR of SMAD4 , an important member of the transforming growth factor-β (TGF-β) signaling pathway, which is a negative regulator of thyroid follicular cell growth (Geraldo et al., 2012 2012 ). It has also been reported that miR-146a and -146b can significantly down-regulate interleukin-1 (IL-1) receptor-associated kinase ( IRAK1 ) and tumor necrosis factor (TNF) receptor-associated factor 6 ( TRAF6 ), two key adaptor/scaffold proteins in the IL-1 and Toll-like receptor (TLR) signaling pathway, known to positively regulate nuclear factor-κB (NF-κB) activity (Bhaumik et al., 2008 2008 ). Other targets of miR-146a and -146b are chemokine receptor 4 ( CXCR4 ) (Labbaye et al., 2008 2008 ) and epidermal growth factor receptor ( EGFR ) (Hurst et al., 2009 2009 ), etc. BRSM1 : breast cancer metastasis suppressor-1; CXCR4 : chemokine receptor 4; EGFR : epidermal growth factor receptor; PLZF : promyelocytic leukaemia zinc-finger; NF-κB : nuclear factor-κB; TRAF6 : tumor necrosis factor receptor-associated factor 6; IRAK1 : interleukin-1 receptor-associated kinase miR-221 and -222 are very similar in sequence, clustered on chromosome X, and are likely transcribed as polycistron (Ciafrè et al., 2005 2005 ). Several targets for the miR-221/222 cluster have been identified (Table 2 2 ). One of them is c-KIT , also called CD117 , a cytokine receptor for stem cell factors expressed on the surface of hematopoietic stem cells and other cell types (Felli et al., 2005 2005 ). More recently, the CDKN1B ( p27 Kip1 ) gene was identified as a target of miR-221 and -222 (Galardi et al., 2007 2007 ; Visone et al., 2007 2007 ). p27 Kip1 is a member of the Cip/Kip family, which is related to cell differentiation, proliferation, migration, and apoptosis (Liu et al., 2012 2012 ). Because p27 Kip1 has a key role in cell cycle, particularly in the G1/S transition, the enforced expression of miR-221 and -222 can stimulate thyroid carcinoma cells to break the G1/S block (Pallante et al., 2010 2010 ). Other studies have also shown that miR-221 can target CDKN1C/p57 that has a critical role in the cell cycle control (Garofalo et al., 2008 2008 ). miRNA Potential target gene Potential function Reference  miR-221/222 c-KIT ( CD117 ) Stem cell factor Felli et al., 2005 2005  miR-221/222 CDKN1B ( p27 Kip1 ) Cell cycle Pallante et al., 2010 2010  miR-221 CDKN1C / p57 Cell cycle control Garofalo et al., 2008 2008 miRNA expression in follicular thyroid carcinomas (FTCs) 1 Follicular adenoma and follicular carcinoma of the thyroid gland with microfollicular architecture are lined by cuboidal epithelial cells (McHenry and Phitayakorn, 2011 2011 ). Because of the significant similarities at morphology and molecule among FTCs and FTAs (Braun and Hüttelmaier, 2011 2011 ), miRNAs may become valuable markers to distinguish these tumors. As shown in Table 3 3 , the most highly up-regulated miRNAs in conventional FTCs were miR-187, -224, -155, -222, and -221, and those in oncocytic variants were miR-187, -221, -339, -183, -222, and -197, whereas the most highly up-regulated miRNAs in conventional FTAs were miR-339, -224, -205, -210, -190, -328, and -342, and those in oncocytic variants were miR-31, -339, -183, -221, -224, and -203 (Nikiforova et al., 2008 2008 ). Weber et al. ( 2006 2006 ) revealed four miRNAs (miR-346, -328, -192, and -197) moderately up-regulated by 1.34–1.82-fold in FTCs when compared to FTAs. Tumor histotype miRNA Specimen type Detecting technique Experimental group Control group Expression rofile Reference 8 Follicular thyroid adenoma (FTA)  Conventional type miR-339, -224, -205, -210, -190, -328, -342 2 Snap-frozen tissue 2 RT-PCR 2 Tumor tissue 2 Normal thyroid tissue 2 Up 2 Nikiforova et al., 2008 2008  Oncocytic type miR-31, -339, -183, -221, -224a, -203 8 8 Follicular thyroid carcinoma (FTC)  Conventional type miR-187, -224, -155, -222, -221, -146b 2 Snap-frozen tissue 2 RT-PCR 2 Tumor tissue 2 Normal thyroid tissue 2 Up 2 Nikiforova et al., 2008 2008  Oncocytic type miR-187, -221, -339, -183, -222a, -197 The potential target genes of miR-197 and -346 are reported as extracellular matrix (ECM) components epidermal growth factor-containing fibulin-like extracellular matrix protein 2 ( EFEMP2 ), tetraspanin 3 ( TSPAN3 ), and activin A receptor type 1 ( ACVR1 ). EFEMP2 seems to have tumor suppressor functions (Gallagher et al., 2001 2001 ; Argraves et al., 2003 2003 ) and was reported to be overexpressed in colon carcinomas but down-expressed in prostate cancer (Wlazlinski et al., 2007 2007 ). TSPAN3 belongs to the tetraspan superfamily, whose members are inversely correlated with the metastatic potential in melanoma (Boucheix et al., 2001 2001 ), and ACVR1 is involved in the control of cell growth (Schulte et al., 2001 2001 ). Colamaio et al. ( 2011 2011 ) found that the miR-191 is down-regulated in FA, FTC, and follicular variant of PTC and identified CDK6 , a serine-threonine kinase involved in the control of cell cycle, as a novel target of miR-191. miRNA expression in poorly differentiated thyroid carcinomas (PDTCs) 1 PDTC is a follicular cell derived from malignant neoplasm, it is intermediate between differentiated thyroid carcinomas and ATCs through morphologically and biologically (Schwertheim et al., 2009 2009 ). Aiming to distinguish the miRNA expression in PDTCs, Schwertheim et al. ( 2009 2009 ) investigated the expression levels of two distinct sets of miRNAs in 15 PDTCs. The results showed that the ‘set 1’ (miR-146b, -181b, -21, -221, and -222) expressions were slightly increased in PDTCs, while they were significantly up-regulated in PTCs and ATCs when compared to normal thyroid tissue. As to ‘set 2’ miRNAs (miR-30d, -125b, -26a, -30a-5p, and -let-7c), which are expressed at low levels in PDTCs and ATCs but are significantly up-regulated in PTCs. The integrated results were useful to discriminate PDTCs from PTCs and ATCs. Nikiforova et al. ( 2008 2008 ) investigated that there were ten miRNAs overexpressed in PDTCs relative to normal thyroid tissues, and further seven miRNAs (miR-187, -221, -129, -222, -146b, -339, and -183) significantly overexpressed in PDTCs as compared with hyperplastic nodules. According to Chiappetta et al. ( 2008 2008 ), high-mobility group AT-hook 2 ( HMGA2 ), which correlates with malignancy in human thyroid neoplasias, was a possible target of miRNA-125b and -26. miRNA expression in anaplastic thyroid cancers (ATCs) 1 As far as ATCs are concerned, the most striking difference between ATCs and other thyroid carcinomas derived from follicular cells is that they displayed a significantly decreased expression of various miRNAs (Visone et al., 2007 2007 ; Schwertheim et al., 2009 2009 ; Braun et al., 2010 2010 ). The most significantly decreased miRNAs in expression were miR-30d, -125b, and -26a (Visone et al., 2007 2007 ; Schwertheim et al., 2009 2009 ). Contrary to the expression in PTCs, miR-138 was found to be severely decreased in ATC samples as well as in ATC-derived cell lines (Mitomo et al., 2008 2008 ; Takakura et al., 2008 2008 ; Braun et al., 2010 2010 ). Braun et al. ( 2010 2010 ) identified two significantly reduced miRNA families that can certainly distinguish ATCs from PTCs and FTCs: miR-200 and miR-30. While recent studies have also revealed up-regulation of several miRNAs in ATCs. Nikiforova et al. ( 2008 2008 ) revealed that miR-302c, -205, and -137 were overexpressed in ATCs when compared to hyperplastic nodules. Visone et al. ( 2007 2007 ) observed four miRNAs (miR-222, -198, -let-7f-1, and -let-7a-2) elevated in ATCs by comparing them with non-transformed thyroid tissues. Takakura et al. ( 2008 2008 ) reported that the miR-17-92 cluster of seven miRNAs (miR-17-5p, -17-3p, -18a, -19a, -20a, -19b, and -92-1) as well as miR-106a and -106b were overexpressed in ATC cell lines. miR-17-3p and -17-5p displayed overexpression also in human ATC samples when compared to normal tissues. Other studies also found that miR-21, -146b, -221, and -222 were overexpressed in ATCs (Mitomo et al., 2008 2008 ; Nikiforova et al., 2008 2008 ; Frezzetti et al., 2011b 2011b ). These findings are summarized in Table 4 4 . PT: cells isolated from thyroid tissues of patients with Graves’ disease miRNA Specimen type Detecting technique Experimental group Control group Expression profile Reference miR-30d, -125b, -26a, -30a-5p Thyroid sample miRNA microarrays ATC Normal thyroid tissue Down Visone et al., 2007 2007 miR-138 Snap-frozen tissue RT-PCR ATC Papillary thyroid carcinoma Down Mitomo et al., 2008 2008 miR-302c, -205, -137, -187, -214, -155, -224, -222, -221 Snap-frozen tissue RT-PCR Tumor tissue Normal thyroid tissue Up Nikiforova et al., 2008 2008 miR-222, -198, -let-7f-1, -let-7a-2 Thyroid sample miRNA microarrays ATC Normal thyroid tissue Up Visone et al., 2007 2007 miR-192, -196a, -194, -429, -200b, -7, -10a, -16 Cell line miRNA microarrays ATC cell lines ARO PT Up Takakura et al., 2008 2008 The research concerning the targets of the miRNAs of ATCs (Table 5 5 ) reveal that the potential target gene of miR-30a may be Beclin 1 , which is a key autophagy-promoting gene that plays a critical role in regulation of cell death and survival of several cell types (Zhu et al., 2009 2009 ). Kota et al. ( 2009 2009 ) demonstrated that cyclins D2 and E2 are potential target genes of miR-26a in liver cancer cells. A potential target of miR-138 is the human telomerase reverse transcriptase ( hTERT ), whose overexpression has been associated with dedifferentiation, tumor stage, and increased metastatic and invasive phenotypes (Mitomo et al., 2008 2008 ). The miR-17 family has been demonstrated to modulate the fibroblast growth factor 10 ( FGF10 ) and fibroblast growth factor receptor 2b ( FGFR2b ), which can modulate epithelial bud morphogenesis in response to FGF10 signaling (Carraro et al., 2009 2009 ). More recently, Esposito et al. ( 2012 2012 ) reported that miR-25 and -30d putatively targeted the polycomb protein enhancer of zeste 2 ( EZH2 ), which has oncogenic activity and was drastically up-regulated in ATCs but not in the differentiated ones. miRNA Potential target gene Potential function Reference miR-30a Beclin 1 Regulate cell death and survival of various cell types Zhu et al., 2009 2009 miR-26a Cyclins D2 and E2 Cell cycle arrest Kota et al., 2009 2009 miR-138 hTERT Dedifferentiation, tumor stage, and increased metastatic and invasive phenotypes Mitomo et al., 2008 2008 miR-17 family STAT3 and MAPK14 Modulate epithelial bud morphogenesis Carraro et al., 2009 2009 miR-25, -30d EZH2 Oncogenic activity Esposito et al., 2012 2012 miRNA expression in medullary thyroid cancers (MTCs) 1 Few studies have been conducted to investigate the function of miRNAs in MTC pathogenesis. Nikiforova et al. ( 2008 2008 ) revealed up-regulation of miR-323, -370, -129, -137, -10a, -124a, -224, -127, -9, and -154, which showed a value of fold-change from 142.2 to 32.3 in MTCs compared to normal thyroid tissues (Table 6 6 ). A study conducted by Abraham et al. ( 2011 2011 ) in a series of 19 patients including 12 SMTC and 7 HMTC and their results, which were further validated by quantitative polymerase chain reaction (qPCR), indicated that miR-183 and miR-375 were overexpressed, whereas miR-9* was down-expressed in SMTC compared with HMTC. Mian et al. ( 2012 2012 ) verified the overexpression of nine miRNAs (miR-21, -127, -154, -224, -323, -370, -9*, -183, and -375) by quantitative real-time PCR (qRT-PCR) in MTC patients. To further study the potential target genes of miR-21, they analyzed the immunohistochemical expression of programmed cell death 4 ( PDCD4 ) and found that the PDCD4 expression was significantly down-regulated in MTC samples in line with the up-regulation of miR-21. HMTC: hereditary medullary thyroid cancer; SMTC: sporadic medullary thyroid cancer miRNA Specimen type Detecting technique Experimental group Control group Expression profile Reference miR-323, -370, -129, -137, -10a, -124a, -224, -127, -9, -154 Snap-frozen tissue RT-PCR Tumor tissue Normal thyroid tissue Up Nikiforova et al., 2008 2008 miR-183, -375 Snap-frozen tissue qPCR SMTC HMTC Up Abraham et al., 2011 2011 miR-9* Snap-frozen tissue qPCR SMTC HMTC Down Abraham et al., 2011 2011 miR-21, -127, -154, -224, -323, -370, -9*, -183, -375 Snap-frozen tissue qRT-PCR MTC Normal thyroid tissue Up Mian et al., 2012 2012 Association between miRNA expression and thyroid tumor invasion 1 The migration and metastasis of cancer cells take place in three steps: adherence, degradation, and movement (Gao et al., 2010 2010 ). In order to invade the circulatory and lymphatic systems to get metastasis, the tumor cells must initiate and completely come through all of these steps (Ponta et al., 2001 2001 ). Gao et al. ( 2010 2010 ) have done experiments between highly metastatic PTC cell lines and common human PTC cell lines to illustrate the relationship between deregulated miRNAs and metastasis of PTCs. The results showed that 11 miRNAs were differentially expressed in the metastatic and control cell lines. Among the 11 miRNAs, 9 (let-7b, miR-222, -106, -193, -34, -29, -26a, -15a, and -200) were reported to have an important role in tumor metastasis (Nikiforova et al., 2008 2008 ) or epithelial-mesenchymal transition (EMT) (Gregory et al., 2008 2008 ; Korpal and Kang, 2008 2008 ; Gebeshuber et al., 2009 2009 ), while another two miRNAs (miR-199b and -16) were respectively involved in the tumor stem cell fate determination and apoptosis (Garzia et al., 2009 2009 ; Guo et al., 2009 2009 ). In another study, Yip et al. ( 2011 2011 ) observed that miR-146b, -221, -222, and -155 were enhanced by up-regulation, while miR-1, -34b, -130b, and -138 were significantly down-regulated in aggressive tumors compared with non-aggressive PTCs. miR-183 and miR-375, which can predict lateral lymph node metastases in MTC, are associated with residual disease, metastases, and mortality (Abraham et al., 2011 2011 ). While high miR-224 levels have been associated with lower stages of diagnosis, and none lymph node metastases or a biochemically free status was at the terminal of the follow-up in MTCs (Mian et al., 2012 2012 ). Because miRNAs play their functions by influencing their target genes, the metastasis-related genes have become the focus of the ongoing research. One study about miR-146b was conducted in vitro in a highly metastatic human breast cancer cell line (Hurst et al., 2009 2009 ). The breast cancer metastasis suppressor 1 ( BRSM1 ) up-regulates miR-146a and -146b, which can suppress breast cancer metastasis since they are likely to reduce the signaling through the NF-κB pathway (Fig. 1 1 ). TSPAN3 , the potential target of miR-197, which belongs to the tetraspan superfamily, was inversely correlated with the metastatic potential in melanoma (Argraves et al., 2003 2003 ; Colamaio et al., 2011 2011 ). One potential target gene of miR-1 is CXCR4 , which is often overexpressed in PTCs and plays a major role in lymph node metastasis from a primary tumor (Castellone et al., 2004 2004 ). Circulating miRNA expression profiles in thyroid tumor 1 There have previously been lots of diagnostic and/or prognostic markers for thyroid tumor tissues or cells from fine-needle aspiration (FNA). Yu et al. ( 2012 2012 ) stuided the relationship between genome-wide serum miRNA expression profiles and thyroid tumors using Solexa sequencing followed by extensive qRT-PCR validation in 245 subjects (106 PTCs, 95 benign nodules, and 44 healthy controls). The results suggested that the expressions of serum let-7e, miR-151-5p, and miR-222 were significantly increased in the PTC cases compared to the benign cases and healthy controls. Receiver operating characteristic curve analyses indicated that these three miRNAs had a high diagnostic sensitivity and specificity for PTCs and their expression levels were well-correlated with certain clinicopathological features, such as nodal status, tumor size, multifocal lesion status, and the tumor-node-metastasis stage. Besides, one important thing of the serum miRNAs profiles may be their convenient and minimally invasive characters as novel diagnostic markers for PTC, though large-scale and multi-center studies are needed. Contribution of single nucleotide polymorphism (SNP) to thyroid tumors 1 SNPs are the most common type of genetic variation which can lead to alterations in miRNA expression resulting in diverse functional consequences (Wang et al., 2012 2012 ), such as population diversity, disease susceptibility, and individual response to medicine (Shastry, 2009 2009 ). SNPs located in miRNA-related regions including primary and precursor miRNA sequences, seed sequence of miRNAs, miRNA processing genes, and 3′ UTR of target genes, can diversify miRNA production and the affinity and specificity between miRNAs and mRNAs (Landi et al., 2012 2012 ). Since a specific miRNA has the ability to regulate hundreds of target mRNAs, SNPs in miRNAs may produce varied functions (Wang et al., 2012 2012 ). Here, miR-146a rs2910164 was one of the most common studied miRNA polymorphisms (Yue et al., 2011 2011 ; Zhou et al., 2011 2011 ). Human miR-146 comes in two distinct forms: miR-146a encoded on chromosome 5q33 and miR-146b encoded on chromosome 10q24 (Jazdzewski et al., 2008 2008 ). The two related miR-146s are differentially regulated, with miR-146a strongly induced by lipopolysaccharide and regulated by NF-κB (Taganov et al., 2006 2006 ; Jazdzewski et al., 2008 2008 ). The miR-146a rs2910164 polymorphism is located at a position +60 relative to the first nucleotide of pre-miR-146a. The G to C change in the passenger strand results in a decreased mature miR-146a (Yue et al., 2011 2011 ). Jazdzewski et al. ( 2008 2008 ) found that the miR-146a rs2910164 CC genotype in pre-miR-146a was associated with a reduced production of mature miR-146a and contributed to a genetic predisposition to PTC. Because miR-146a is known to be an NF-κB-dependent gene (Taganov et al., 2006 2006 ; Cameron et al., 2008 2008 ) and can inhibit the downstream target genes, TRAF6 and IRAK1 , two key downstream adapter molecules of the TLR and cytokine receptors, Jazdzewski et al. ( 2008 2008 ) speculated that the SNP can affect the negative feedback regulation loop in TLR and cytokine signaling pathway. Correlation of somatic mutations with deregulated miRNA expression in thyroid tumors 1 Recent studies have suggested that genetic alterations in oncogenes may be of clinical use in thyroid neoplasms. The most common genetic alterations occurring in thyroid cancers are related with signal transduction pathways, including tyrosine kinase receptors [ RET/PTC and neurotrophic tyrosine receptor kinase ( NTRK )], signaling proteins ( BRAF and RAS ), and nuclear proteins [paired box ( PAX ) 8 and peroxisome proliferator-activated receptor γ ( PPAR-γ )] (Vriens et al., 2009 2009 ). These genetic changes are always mutually exclusive (Shibru et al., 2008 2008 ) and have something to show about the deregulated miRNAs. Mutation of the BRAF gene is most prominent in PTCs with an appearance up to 50% (Kondo et al., 2006 2006 ; Pallante et al., 2010 2010 ). The BRAF mutation in primary PTC is a T-A substitution at nucleotide 1799 in exon 15, which results in a change from valine acid to glutamic acid at codon 600 (V600E) of the BRAF protein (Wellbrock et al., 2004 2004 ; Wojciechowska and Lewinski, 2006 2006 ; Mitsiades et al., 2007 2007 ), resulting in activation of the mitogen-activated protein kinase (MAPK) pathway (Wan et al., 2004 2004 ; Knauf et al., 2005 2005 ). The presence of a BRAF mutation has been associated with the poorer prognosis in PTC patients, such as an advanced stage at diagnosis, extrathyroidal extension, and lymph node metastasis (Xing, 2007 2007 ; Elisei et al., 2008a 2008a ; Yip et al., 2009 2009 ). Recently, studies aiming to show an association between BRAF positivity and miR-146b in aggressive PTCs (Chou et al., 2010 2010 ; Yip et al., 2011 2011 ) found that miR-146b was significantly overexpressed in BRAF -positive PTCs with aggressive tumor behaviors. Mutations of the RAS genes ( K-RAS , H-RAS , and N-RAS presented in codons 12, 13, and 61, respectively) were found in all thyroid cancers. The mutation frequencies are 10%–20% in PTCs, 20%–40% in FTAs, 40%–50% in FTCs, 20%–55% in PDTCs, and 20%–60% in ATCs (Kondo et al., 2006 2006 ; Pallante et al., 2010 2010 ). RAS proteins are plasma membrane GTPases activated by growth factor receptors, non-receptor tyrosine kinases, and G-protein-coupled receptors (Fagin and Mitsiades, 2008 2008 ). It was reported that RAS -positive PTCs expressed the highest amount of miR-146 (Nikiforova et al., 2008 2008 ). RET rearrangement is caused by inter-chromosomal translocations and there have been reported a total of 15 different RET/PTC rearrangements. The most widely occurring are RET/PTC1 (RET kinase fused with H4 gene) and RET/PTC3 (RET kinase fused with RFG gene) (Pallante et al., 2010 2010 ). Nikiforova et al. ( 2008 2008 ) reported that miR-187 was expressed at high levels in PTCs harboring RET/PTC rearrangements, while miR-221 and -222 were found at the highest level in BRAF - and RAS -positive PTCs. The frequencies of RET rearrangements are lower in PTCs (20%–40%) and PDTCs (~10%) (Vriens et al., 2009 2009 ; Braun and Hüttelmaier, 2011 2011 ). However, it has been documented that the frequency of RET rearrangement in MTC cases is in the range of 40%–50% (Elisei et al., 2008b 2008b ). And significantly lower miR-127 levels were observed in SMTC carrying somatic RET mutations in comparison to SMTC carrying a wild-type RET (Mian et al., 2012 2012 ). Summary 1 MicroRNAs constitute a recently identified class of small endogenous noncoding RNAs that act as negative regulators of the protein-coding gene expression and may impact cell differentiation, proliferation, and survival, i.e., all fundamental cellular processes implicated in carcinogenesis. The miRNA expressiones are deregulated in many types of human cancers, including thyroid cancer. There are many types of thyroid carcinomas, such as PTCs, FTCs, ATCs, and MTCs. Several studies have shown the deregulation of miRNA expression in human thyroid carcinomas, such as miR-146, -221, -222, -155, and -181a up-regulated in human PTC as compared with normal human tissue; miR-192, -197, -328, and -346 overexpressed in FTC as compared with Fas; and, miR-17-92 cluster overexpressed in ATC cell lines as compared with normal tissues and follicular carcinoma cell lines. Among these deregulated miRNAs, some have relevance with the thyroid tumor invasion and metastasis. Besides, circulating miRNA (serum or peripheral blood miRNAs) expression profiles in thyroid tumor have been studied recently, as novel diagnostic and/or prognostic tools. SNPs, as the most common type of genetic variation, which exist in miRNA genes, can lead to diverse functional consequences, including thyroid carcinomas. And the somatic mutations have relevance with the deregulated miRNA expression in thyroid tumors. For example, miR-146b was significantly overexpressed in the BRAF -positive PTC that also had aggressive tumor behaviors and it was reported that RAS -positive PTCs expressed the highest amount of miR-146. In this review, the documented miRNA profiles and their potential target genes in each type of thyroid tumor were summarized. We also recorded the latest researches on circulating miRNA expression profiles in thyroid tumors and the contribution of SNPs to thyroid tumors, in order to contribute to the search for thyroid tumor diagnosis and treatment. References D Abraham , N Jackson , JS Gundara , 等 . MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets . Clin Cancer Res , 2011 . 17 ( 14 ): 4772 - 4781 . 21622722 DOI: 10.1158/1078-0432.CCR-11-0242 http://doi.org/10.1158/1078-0432.CCR-11-0242 . MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets P Agretti , E Ferrarini , T Rago , 等 . MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration . Eur J Endocrinol , 2012 . 167 ( 3 ): 393 - 400 . 22728346 DOI: 10.1530/EJE-12-0400 http://doi.org/10.1530/EJE-12-0400 . MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration V Ambros . The functions of animal microRNAs . Nature , 2004 . 431 ( 7006 ): 350 - 355 . 15372042 DOI: 10.1038/nature02871 http://doi.org/10.1038/nature02871 . The functions of animal microRNAs WS Argraves , LM Greene , MA Cooley , 等 . Fibulins: physiological and disease perspectives . EMBO Rep , 2003 . 4 ( 12 ): 1127 - 1131 . 14647206 DOI: 10.1038/sj.embor.7400033 http://doi.org/10.1038/sj.embor.7400033 . Fibulins: physiological and disease perspectives DP Bartel . MicroRNAs: genomics, biogenesis, mechanism, and function . Cell , 2004 . 116 ( 2 ): 281 - 297 . 14744438 DOI: 10.1016/S0092-8674(04)00045-5 http://doi.org/10.1016/S0092-8674(04)00045-5 . MicroRNAs: genomics, biogenesis, mechanism, and function D Bhaumik , GK Scott , S Schokrpur , 等 . Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells . Oncogene , 2008 . 27 ( 42 ): 5643 - 5647 . 18504431 DOI: 10.1038/onc.2008.171 http://doi.org/10.1038/onc.2008.171 . Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells C Boucheix , GH Duc , C Jasmin , 等 . Tetraspanins and malignancy . Expert Rev Mol Med , 2001 . 3 ( 4 ): 1 - 17 . DOI: 10.1017/S1462399401002381 http://doi.org/10.1017/S1462399401002381 . Tetraspanins and malignancy J Braun , S Hüttelmaier . Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin . Thyroid Res , 2011 . 4 ( Suppl. 1 ): S1 21835047 DOI: 10.1186/1756-6614-4-S1-S1 http://doi.org/10.1186/1756-6614-4-S1-S1 . Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin J Braun , C Hoang-Vu , H Dralle , 等 . Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas . Oncogene , 2010 . 29 ( 29 ): 4237 - 4244 . 20498632 DOI: 10.1038/onc.2010.169 http://doi.org/10.1038/onc.2010.169 . Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas JE Cameron , Q Yin , C Fewell , 等 . Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways . J Virol , 2008 . 82 ( 4 ): 1946 - 1958 . 18057241 DOI: 10.1128/JVI.02136-07 http://doi.org/10.1128/JVI.02136-07 . Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways G Carraro , A El-Hashash , D Guidolin , 等 . miR-17 family of microRNAs controls FGF10 -mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-cadherin distribution . Dev Biol , 2009 . 333 ( 2 ): 238 - 250 . 19559694 DOI: 10.1016/j.ydbio.2009.06.020 http://doi.org/10.1016/j.ydbio.2009.06.020 . miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-cadherin distribution MD Castellone , V Guarino , V de Falco , 等 . Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas . Oncogene , 2004 . 23 ( 35 ): 5958 - 5967 . 15184868 DOI: 10.1038/sj.onc.1207790 http://doi.org/10.1038/sj.onc.1207790 . Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas YT Chen , N Kitabayashi , XK Zhou , 等 . MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma . Mod Pathol , 2008 . 21 ( 9 ): 1139 - 1146 . 18587330 DOI: 10.1038/modpathol.2008.105 http://doi.org/10.1038/modpathol.2008.105 . MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma G Chiappetta , A Ferraro , E Vuttariello , 等 . HMGA2 mRNA expression correlates with the malignant phenotypein human thyroid neoplasias . Eur J Cancer , 2008 . 44 ( 7 ): 1015 - 1021 . 18375116 DOI: 10.1016/j.ejca.2008.02.039 http://doi.org/10.1016/j.ejca.2008.02.039 . HMGA2 mRNA expression correlates with the malignant phenotypein human thyroid neoplasias L Chin , WC Hahn , G Getz , 等 . Making sense of cancer genomic data . Genes Dev , 2011 . 25 ( 6 ): 534 - 555 . 21406553 DOI: 10.1101/gad.2017311 http://doi.org/10.1101/gad.2017311 . Making sense of cancer genomic data CK Chou , RF Chen , FF Chou , 等 . miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF V600E mutation . Thyroid , 2010 . 20 ( 5 ): 489 - 494 . 20406109 DOI: 10.1089/thy.2009.0027 http://doi.org/10.1089/thy.2009.0027 . miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAFV600E mutation SA Ciafrè , S Galardi , A Mangiola , 等 . Extensive modulation of a set of microRNAs in primary glioblastoma . Biochem Biopys Res Commun , 2005 . 334 ( 4 ): 1351 - 1358 . DOI: 10.1016/j.bbrc.2005.07.030 http://doi.org/10.1016/j.bbrc.2005.07.030 . Extensive modulation of a set of microRNAs in primary glioblastoma M Colamaio , E Borbone , L Russo , 等 . miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting . J Clin Endocrinol Metab , 2011 . 96 ( 12 ): E1915 - E1924 . 21956418 DOI: 10.1210/jc.2011-0408 http://doi.org/10.1210/jc.2011-0408 . miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting JB Cowland , C Hother , K Grønbaek . MicroRNAs and cancer . APMIS , 2007 . 115 ( 10 ): 1090 - 1106 . 18042145 DOI: 10.1111/j.1600-0463.2007.apm_775.xml.x http://doi.org/10.1111/j.1600-0463.2007.apm_775.xml.x . MicroRNAs and cancer DS Dean , H Gharib . Epidemiology of thyroid nodules . Best Pract Res Clin Endocrinol Metab , 2008 . 22 ( 6 ): 901 - 911 . 19041821 DOI: 10.1016/j.beem.2008.09.019 http://doi.org/10.1016/j.beem.2008.09.019 . Epidemiology of thyroid nodules R Elisei , C Ugolini , D Viola , 等 . BRAF V600E mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study . J Clin Endocrinol Metab , 2008 . 93 ( 10 ): 3943 - 3949 . 18682506 DOI: 10.1210/jc.2008-0607 http://doi.org/10.1210/jc.2008-0607 . BRAFV600E mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study R Elisei , B Cosci , C Romei , 等 . Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study . J Clin Endocrinol Metab , 2008 . 93 ( 3 ): 682 - 687 . 18073307 DOI: 10.1210/jc.2007-1714 http://doi.org/10.1210/jc.2007-1714 . Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study F Esposito , M Tornincasa , P Pallante , 等 . Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2 . J Clin Endocrinol Metab , 2012 . 97 ( 5 ): E710 - E718 . 22399519 DOI: 10.1210/jc.2011-3068 http://doi.org/10.1210/jc.2011-3068 . Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2 JA Fagin , N Mitsiades . Molecular pathology of thyroid cancer: diagnostic and clinical implications . Best Pract Res Clin Endocrinol Metab , 2008 . 22 ( 6 ): 955 - 969 . 19041825 DOI: 10.1016/j.beem.2008.09.017 http://doi.org/10.1016/j.beem.2008.09.017 . Molecular pathology of thyroid cancer: diagnostic and clinical implications N Felli , L Fontana , E Pelosi , 等 . MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation . PNAS , 2005 . 102 ( 50 ): 18081 - 18086 . 16330772 DOI: 10.1073/pnas.0506216102 http://doi.org/10.1073/pnas.0506216102 . MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation C Ferraz , M Eszlinger , R Paschke . Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules . J Clin Endocrinol Metab , 2011 . 96 ( 7 ): 2016 - 2026 . 21593119 DOI: 10.1210/jc.2010-2567 http://doi.org/10.1210/jc.2010-2567 . Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules D Frezzetti , C Reale , G Calì , 等 . The microRNA-processing enzyme Dicer is essential for thyroid function . PLoS ONE , 2011 . 6 ( 11 ): e27648 22132122 DOI: 10.1371/journal.pone.0027648 http://doi.org/10.1371/journal.pone.0027648 . The microRNA-processing enzyme Dicer is essential for thyroid function D Frezzetti , M de Menna , P Zoppoli , 等 . Upregulation of miR-21 by Ras in vivo and its role in tumor growth . Oncogene , 2011 . 30 ( 3 ): 275 - 286 . 20956945 DOI: 10.1038/onc.2010.416 http://doi.org/10.1038/onc.2010.416 . Upregulation of miR-21 by Ras in vivo and its role in tumor growth S Galardi , N Mercatelli , E Giorda , 等 . miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27 Kip1 . J Biol Chem , 2007 . 282 ( 32 ): 23716 - 23724 . 17569667 DOI: 10.1074/jbc.M701805200 http://doi.org/10.1074/jbc.M701805200 . miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 WM Gallagher , LM Greene , MP Ryan , 等 . Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues . FEBS Lett , 2001 . 489 ( 1 ): 59 - 66 . 11231014 DOI: 10.1016/S0014-5793(00)02389-9 http://doi.org/10.1016/S0014-5793(00)02389-9 . Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues Y Gao , C Wang , Z Shan , 等 . miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness . Endocr J , 2010 . 57 ( 1 ): 81 - 86 . 19851034 DOI: 10.1507/endocrj.K09E-220 http://doi.org/10.1507/endocrj.K09E-220 . miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness M Garofalo , C Quintavalle , G di Leva , 等 . MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer . Oncogene , 2008 . 27 ( 27 ): 3845 - 3855 . 18246122 DOI: 10.1038/onc.2008.6 http://doi.org/10.1038/onc.2008.6 . MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer L Garzia , I Andolfo , E Cusanelli , 等 . MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma . PLoS ONE , 2009 . 4 ( 3 ): e4998 19308264 DOI: 10.1371/journal.pone.0004998 http://doi.org/10.1371/journal.pone.0004998 . MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma CA Gebeshuber , K Zatloukal , J Martinez . miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis . EMBO Rep , 2009 . 10 ( 4 ): 400 - 405 . 19247375 DOI: 10.1038/embor.2009.9 http://doi.org/10.1038/embor.2009.9 . miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis MV Geraldo , AS Yamashita , ET Kimura . MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer . Oncogene , 2012 . 31 ( 15 ): 1910 - 1922 . 21874046 DOI: 10.1038/onc.2011.381 http://doi.org/10.1038/onc.2011.381 . MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer H Gharib . Changing trends in thyroid practice: understanding nodular thyroid disease . Endocr Pract , 2004 . 10 ( 1 ): 31 - 39 . 15251619 DOI: 10.4158/EP.10.1.31 http://doi.org/10.4158/EP.10.1.31 . Changing trends in thyroid practice: understanding nodular thyroid disease PA Gregory , CP Bracken , AG Bert , 等 . MicroRNAs as regulators of epithelial-mesenchymal transition . Cell Cycle , 2008 . 7 ( 20 ): 3112 - 3118 . 18927505 . MicroRNAs as regulators of epithelial-mesenchymal transition CJ Guo , Q Pan , DG Li , 等 . miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis . J Hepatol , 2009 . 50 ( 4 ): 766 - 778 . 19232449 DOI: 10.1016/j.jhep.2008.11.025 http://doi.org/10.1016/j.jhep.2008.11.025 . miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis H He , K Jazdzewski , W Li , 等 . The role of microRNA genes in papillary thyroid carcinoma . PNAS , 2005 . 102 ( 52 ): 19075 - 19080 . 16365291 DOI: 10.1073/pnas.0509603102 http://doi.org/10.1073/pnas.0509603102 . The role of microRNA genes in papillary thyroid carcinoma Y Huang , XJ Shen , Q Zou , 等 . Biological functions of microRNAs: a review . J Physiol Biochem , 2010 . 67 ( 1 ): 129 - 139 . 20981514 DOI: 10.1007/s13105-010-0050-6 http://doi.org/10.1007/s13105-010-0050-6 . Biological functions of microRNAs: a review DR Hurst , MD Edmonds , GK Scott , 等 . Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis . Cancer Res , 2009 . 69 ( 4 ): 1279 - 1283 . 19190326 DOI: 10.1158/0008-5472.CAN-08-3559 http://doi.org/10.1158/0008-5472.CAN-08-3559 . Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis K Jazdzewski , EL Murray , K Franssila , 等 . Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma . PNAS , 2008 . 105 ( 20 ): 7269 - 7274 . 18474871 DOI: 10.1073/pnas.0802682105 http://doi.org/10.1073/pnas.0802682105 . Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma JA Knauf , X Ma , EP Smith , 等 . Targeted expression of BRAF V600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation . Cancer Res , 2005 . 65 ( 10 ): 4238 - 4245 . 15899815 DOI: 10.1158/0008-5472.CAN-05-0047 http://doi.org/10.1158/0008-5472.CAN-05-0047 . Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation T Kondo , S Ezzat , SL Asa . Pathogenetic mechanisms in thyroid follicular-cell neoplasia . Nat Rev Cancer , 2006 . 6 ( 4 ): 292 - 306 . 16557281 DOI: 10.1038/nrc1836 http://doi.org/10.1038/nrc1836 . Pathogenetic mechanisms in thyroid follicular-cell neoplasia M Korpal , Y Kang . The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis . RNA Biol , 2008 . 5 ( 3 ): 115 - 119 . 19182522 . The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis J Kota , RR Chivukula , KA O′Donnell , 等 . Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model . Cell , 2009 . 137 ( 6 ): 1005 - 1017 . 19524505 DOI: 10.1016/j.cell.2009.04.021 http://doi.org/10.1016/j.cell.2009.04.021 . Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model G Ku , MT McManus . Behind the scenes of a small RNA gene-silencing pathway . Hum Gene Ther , 2008 . 19 ( 1 ): 17 - 26 . 18211225 DOI: 10.1089/hum.2007.1226 http://doi.org/10.1089/hum.2007.1226 . Behind the scenes of a small RNA gene-silencing pathway C Labbaye , I Spinello , MT Quaranta , 等 . A three-step pathway comprising PLZF /miR-146a/ CXCR4 controls megakaryopoiesis . Nat Cell Biol , 2008 . 10 ( 7 ): 788 - 801 . 18568019 DOI: 10.1038/ncb1741 http://doi.org/10.1038/ncb1741 . A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis D Landi , F Gemignani , S Landi . Role of variations within microRNA-binding sites in cancer . Mutagenesis , 2012 . 27 ( 2 ): 205 - 210 . 22294768 DOI: 10.1093/mutage/ger055 http://doi.org/10.1093/mutage/ger055 . Role of variations within microRNA-binding sites in cancer V Leone , D D′Angelo , I Rubio , 等 . miR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2 , CXCR4 , and SDF-1α . J Clin Endocrinol Metab , 2011 . 96 ( 9 ): E1388 - E1398 . 21752897 DOI: 10.1210/jc.2011-0345 http://doi.org/10.1210/jc.2011-0345 . miR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1α X Liu , Y Cheng , J Yang , 等 . Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application . J Mol Cell Cardiol , 2012 . 52 ( 1 ): 245 - 255 . 22138289 DOI: 10.1016/j.yjmcc.2011.11.008 http://doi.org/10.1016/j.yjmcc.2011.11.008 . Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application F Marini , E Luzi , ML Brandi . MicroRNA role in thyroid cancer development . J Thyroid Res , 2011 . 2011 407123 21687652 DOI: 10.4061/2011/407123 http://doi.org/10.4061/2011/407123 . MicroRNA role in thyroid cancer development MD Mattie , CC Benz , J Bowers , 等 . Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies . Mol Cancer , 2006 . 5 ( 1 ): 24 16784538 DOI: 10.1186/1476-4598-5-24 http://doi.org/10.1186/1476-4598-5-24 . Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies H Mazeh . MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules . Oncologist , 2012 . 17 ( 8 ): 1032 - 1038 . 22707512 DOI: 10.1634/theoncologist.2012-0013 http://doi.org/10.1634/theoncologist.2012-0013 . MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules CR McHenry , R Phitayakorn . Follicular adenoma and carcinoma of the thyroid gland . Oncologist , 2011 . 16 ( 5 ): 585 - 593 . 21482585 DOI: 10.1634/theoncologist.2010-0405 http://doi.org/10.1634/theoncologist.2010-0405 . Follicular adenoma and carcinoma of the thyroid gland MP Menon , A Khan . micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications . J Clin Pathol , 2009 . 62 ( 11 ): 978 - 985 . 19625289 DOI: 10.1136/jcp.2008.063909 http://doi.org/10.1136/jcp.2008.063909 . micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications C Mian , G Pennelli , M Fassan , 等 . MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome . Thyroid , 2012 . 22 ( 9 ): 890 - 896 . 22747440 DOI: 10.1089/thy.2012.0045 http://doi.org/10.1089/thy.2012.0045 . MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome S Mitomo , C Maesawa , S Ogasawara , 等 . Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines . Cancer Sci , 2008 . 99 ( 2 ): 280 - 286 . 18201269 DOI: 10.1111/j.1349-7006.2007.00666.x http://doi.org/10.1111/j.1349-7006.2007.00666.x . Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines CS Mitsiades , J Negri , C McMullan , 等 . Targeting BRAF V600E in thyroid carcinoma: therapeutic implications . Mol Cancer Ther , 2007 . 6 ( 3 ): 1070 - 1078 . 17363500 DOI: 10.1158/1535-7163.MCT-06-0449 http://doi.org/10.1158/1535-7163.MCT-06-0449 . Targeting BRAFV600E in thyroid carcinoma: therapeutic implications Y Murakami , T Yasuda , K Saigo , 等 . Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues . Oncogene , 2006 . 25 ( 17 ): 2537 - 2545 . 16331254 DOI: 10.1038/sj.onc.1209283 http://doi.org/10.1038/sj.onc.1209283 . Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues YE Nikiforov , MN Nikiforova . Molecular genetics and diagnosis of thyroid cancer . Nat Rev Endocrinol , 2011 . 7 ( 10 ): 569 - 580 . 21878896 DOI: 10.1038/nrendo.2011.142 http://doi.org/10.1038/nrendo.2011.142 . Molecular genetics and diagnosis of thyroid cancer MN Nikiforova , GC Tseng , D Steward , 等 . MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility . J Clin Endocrinol Metab , 2008 . 93 ( 5 ): 1600 - 1608 . 18270258 DOI: 10.1210/jc.2007-2696 http://doi.org/10.1210/jc.2007-2696 . MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility MN Nikiforova , SI Chiosea , YE Nikiforov . MicroRNA expression profiles in thyroid tumors . Endocr Pathol , 2009 . 20 ( 2 ): 85 - 91 . 19352602 DOI: 10.1007/s12022-009-9069-z http://doi.org/10.1007/s12022-009-9069-z . MicroRNA expression profiles in thyroid tumors P Pallante , R Visone , CM Croce , 等 . Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas . Endocr Relat Cancer , 2010 . 17 ( 1 ): 91 - 104 . DOI: 10.1677/ERC-09-0217 http://doi.org/10.1677/ERC-09-0217 . Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas H Ponta , M Hofmann , P Herrlich . Recent advances in the genetics of metastasis . Eur J Cancer , 2001 . 30A ( 13 ): 1995 - 2001 . . Recent advances in the genetics of metastasis JC Ricarte-Filho , CS Fuziwara , AS Yamashita , 等 . Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer . Transl Oncol , 2009 . 2 ( 4 ): 236 - 241 . 19956384 . Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer KM Schulte , C Jonas , R Krebs , 等 . Activin A and activin receptors in thyroid cancer . Thyroid , 2001 . 11 ( 1 ): 3 - 14 . 11272093 DOI: 10.1089/10507250150500603 http://doi.org/10.1089/10507250150500603 . Activin A and activin receptors in thyroid cancer S Schwertheim , SY Sheu , K Worm , 等 . Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma . Horm Metab Res , 2009 . 41 ( 6 ): 475 - 481 . 19370508 DOI: 10.1055/s-0029-1215593 http://doi.org/10.1055/s-0029-1215593 . Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma BS Shastry . AA Komar . SNPs: impact on gene function and phenotype . Single Nucleotide Polymorphisms , 2009 . Springer , 3 - 22 . DOI: 10.1007/978-1-60327-411-1_1 http://doi.org/10.1007/978-1-60327-411-1_1 . SNPs: impact on gene function and phenotype SY Sheu , F Grabellus , S Schwertheim , 等 . Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours . Br J Cancer , 2010 . 102 ( 2 ): 376 - 382 . 20029416 DOI: 10.1038/sj.bjc.6605493 http://doi.org/10.1038/sj.bjc.6605493 . Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours D Shibru , KW Chung , E Kebebew . Recent developments in the clinical application of thyroid cancer biomarkers . Curr Opin Oncol , 2008 . 20 ( 1 ): 13 - 18 . 18043251 DOI: 10.1097/CCO.0b013e3282f27e49 http://doi.org/10.1097/CCO.0b013e3282f27e49 . Recent developments in the clinical application of thyroid cancer biomarkers KD Taganov , MP Boldin , KJ Chang , 等 . NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses . PNAS , 2006 . 103 ( 33 ): 12481 - 12486 . 16885212 DOI: 10.1073/pnas.0605298103 http://doi.org/10.1073/pnas.0605298103 . NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses S Takakura , N Mitsutake , M Nakashima , 等 . Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells . Cancer Sci , 2008 . 99 ( 6 ): 1147 - 1154 . 18429962 DOI: 10.1111/j.1349-7006.2008.00800.x http://doi.org/10.1111/j.1349-7006.2008.00800.x . Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells MT Tetzlaff , A Liu , X Xu , 等 . Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues . Endocr Pathol , 2007 . 18 ( 3 ): 163 - 173 . 18058265 DOI: 10.1007/s12022-007-0023-7 http://doi.org/10.1007/s12022-007-0023-7 . Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues R Visone , P Pallante , A Vecchione , 等 . Specific microRNAs are downregulated in human thyroid anaplastic carcinomas . Oncogene , 2007 . 26 ( 54 ): 7590 - 7595 . 17563749 DOI: 10.1038/sj.onc.1210564 http://doi.org/10.1038/sj.onc.1210564 . Specific microRNAs are downregulated in human thyroid anaplastic carcinomas MR Vriens , JM Schreinemakers , I Suh , 等 . Diagnostic markers and prognostic factors in thyroid cancer . Future Oncol , 2009 . 5 ( 8 ): 1283 - 1293 . 19852742 DOI: 10.2217/fon.09.85 http://doi.org/10.2217/fon.09.85 . Diagnostic markers and prognostic factors in thyroid cancer MR Vriens , J Weng , I Suh , 等 . MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer . Cancer , 2012 . 118 ( 13 ): 3426 - 3432 . 22006248 DOI: 10.1002/cncr.26587 http://doi.org/10.1002/cncr.26587 . MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer PT Wan , MJ Garnett , SM Roe , 等 . Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF . Cell , 2004 . 116 ( 6 ): 855 - 867 . 15035987 DOI: 10.1016/S0092-8674(04)00215-6 http://doi.org/10.1016/S0092-8674(04)00215-6 . Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF J Wang , Q Wang , H Liu , 等 . The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies . Mutagenesis , 2012 . 27 ( 6 ): 779 - 788 . 22952151 DOI: 10.1093/mutage/ges052 http://doi.org/10.1093/mutage/ges052 . The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies F Weber , RE Teresi , CE Broelsch , 等 . A limited set of human microRNA is deregulated in follicular thyroid carcinoma . J Clin Endocrinol Metab , 2006 . 91 ( 9 ): 3584 - 3591 . 16822819 DOI: 10.1210/jc.2006-0693 http://doi.org/10.1210/jc.2006-0693 . A limited set of human microRNA is deregulated in follicular thyroid carcinoma C Wellbrock , M Karasarides , R Marais . The RAF proteins take centre stage . Nat Rev Mol Cell Biol , 2004 . 5 ( 11 ): 875 - 885 . 15520807 DOI: 10.1038/nrm1498 http://doi.org/10.1038/nrm1498 . The RAF proteins take centre stage A Wlazlinski , R Engers , MJ Hoffmann , 等 . Downregulation of several fibulin genes in prostate cancer . Prostate , 2007 . 67 ( 16 ): 1770 - 1780 . 17929269 DOI: 10.1002/pros.20667 http://doi.org/10.1002/pros.20667 . Downregulation of several fibulin genes in prostate cancer K Wojciechowska , A Lewinski . BRAF mutations in papillary thyroid carcinoma . Endocr Regul , 2006 . 40 ( 4 ): 129 - 138 . 17201587 . BRAF mutations in papillary thyroid carcinoma M Xing . BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications . Endocr Rev , 2007 . 28 ( 7 ): 742 - 762 . 17940185 DOI: 10.1210/er.2007-0007 http://doi.org/10.1210/er.2007-0007 . BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications Y Xiong , L Zhang , AK Holloway , 等 . miR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer . PLoS ONE , 2011 . 6 ( 10 ): e24717 21998631 DOI: 10.1371/journal.pone.0024717 http://doi.org/10.1371/journal.pone.0024717 . miR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer T Yau , CY Lo , RJ Epstein , 等 . Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy . Ann Surg Oncol , 2008 . 15 ( 9 ): 2500 - 2505 . 18581185 DOI: 10.1245/s10434-008-0005-0 http://doi.org/10.1245/s10434-008-0005-0 . Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy L Yip , MN Nikiforova , SE Carty , 等 . Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation . Surgery , 2009 . 146 ( 6 ): 1215 - 1223 . 19958951 DOI: 10.1016/j.surg.2009.09.011 http://doi.org/10.1016/j.surg.2009.09.011 . Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation L Yip , L Kelly , Y Shuai , 等 . MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma . Ann Surg Oncol , 2011 . 18 ( 7 ): 2035 - 2041 . 21537871 DOI: 10.1245/s10434-011-1733-0 http://doi.org/10.1245/s10434-011-1733-0 . MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma S Yu , Y Liu , J Wang , 等 . Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma . J Clin Endocrinol Metab , 2012 . 97 ( 6 ): 2084 - 2092 . 22472564 DOI: 10.1210/jc.2011-3059 http://doi.org/10.1210/jc.2011-3059 . Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma C Yue , M Wang , B Ding , 等 . Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population . Gynecol Oncol , 2011 . 122 ( 1 ): 33 - 37 . 21529907 DOI: 10.1016/j.ygyno.2011.03.032 http://doi.org/10.1016/j.ygyno.2011.03.032 . Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population B Zhou , K Wang , Y Wang , 等 . Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma . Mol Carcinog , 2011 . 50 ( 7 ): 499 - 505 . 21319225 DOI: 10.1002/mc.20740 http://doi.org/10.1002/mc.20740 . Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma H Zhu , H Wu , X Liu , 等 . Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells . Autophagy , 2009 . 5 ( 6 ): 816 - 823 . 19535919 . Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells Compliance with ethics guidelines Zi-ming YUAN, Zhi-li YANG, and Qi ZHENG declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors. 10.1631/jzus.B1300192 Project supported by the National Natural Science Foundation of China (No. 81272935) 2013-06-17 2014-02-21 2013-11-11 2022-01-05 Copyright © Zhejiang University and Springer-Verlag Berlin Heidelberg 2014 2014 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 03 15